For patients with breast cancer, double mastectomy does not reduce mortality
the ONA take:
According to a new study published in The Journal of the American Medical Association, despite an increase in the number of women undergoing a double mastectomy for early-stage breast cancer, the procedure does not reduce the risk of mortality compared with breast-conserving therapy with radiation.
In the study, researchers identified 189,734 women diagnosed with early-stage unilateral breast cancer between 1998 and 2011 from the California Cancer Registry. Researchers followed the patients for an average of approximately 89 months.
They found that the rate of women with early-stage breast cancer undergoing double mastectomies rose from 2% to 12.3% in 1998 and 2011, respectively. Women aged 40 and over opting for the procedure rose from 3.6% to 33% in 1998 and 2011, respectively, making this group have the highest increase. Furthermore, the rate of women undergoing unilateral mastectomies decreased during this period.
In addition, the team found that women who chose to undergo a double mastectomy did not have a lower risk of mortality compared with women who underwent breast-conserving therapy plus radiation. Women who underwent a unilateral mastectomy were found to have a higher risk of death.
The procedure does not reduce the risk of mortality.
Having a double mastectomy for early-stage breast cancer is not linked to a lower risk of death than breast-conserving therapy plus radiation, but still there is an increase in the number of women undergoing the procedure. These are the findings of a new study published in JAMA.
This is not the first study to question the benefits of a double mastectomy, or bilateral mastectomy - the removal of both breasts - for breast cancer patients. Earlier this year, Medical News Today reported on a study published in JAMA Surgery claiming the procedure is unnecessary for the majority of women.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|